lobbying_activities: 3235622

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3235622	fe799f7e-a0b8-4ca4-8351-a5d670c1988b	Q3	BOSTON SCIENTIFIC CORPORATION	66716	BOSTON SCIENTIFIC CORPORATION	2024	third_quarter	SCI	Sen. Schumer's "SAFE" Innovative Framework and Sens. Thune and Klobuchar's AI Research, Innovation and Accountability Act of 2023 (S.3312) - advocacy and education efforts to ensure that FDA retains regulatory authority over artificial intelligence used in medical devices to avoid any harmful regulations that could impair patient access to devices or hinder innovation. American Privacy Rights Act of 2024 (H.R. 8818) - advocacy for inclusion of an exemption for biomedical research that is compliant with an existing regulatory framework for human subjects research to avoid unintended conflicts and burdens; advocacy for inclusion of an exemption for information maintained by an entity that meets the definition of Health Care Provider under HIPAA to prevent unintended negative impacts on patient care, and avoid unnecessary lawsuits for uses and disclosures of patient data that are enabled under HIPAA and critical to a functioning healthcare system.	HOUSE OF REPRESENTATIVES,SENATE		380000	0	0	2024-10-11T15:26:58-04:00